WO2019147044A1 - Composition for animal feed comprising phlorotannin as active ingredient and product for animal - Google Patents

Composition for animal feed comprising phlorotannin as active ingredient and product for animal Download PDF

Info

Publication number
WO2019147044A1
WO2019147044A1 PCT/KR2019/001025 KR2019001025W WO2019147044A1 WO 2019147044 A1 WO2019147044 A1 WO 2019147044A1 KR 2019001025 W KR2019001025 W KR 2019001025W WO 2019147044 A1 WO2019147044 A1 WO 2019147044A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
ecklonia
animal
product
Prior art date
Application number
PCT/KR2019/001025
Other languages
French (fr)
Korean (ko)
Inventor
이행우
김성호
천현철
윤진석
강문석
Original Assignee
주식회사 헤마스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 헤마스 filed Critical 주식회사 헤마스
Priority to CN201980009505.5A priority Critical patent/CN111669976A/en
Publication of WO2019147044A1 publication Critical patent/WO2019147044A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/24Compounds of alkaline earth metals, e.g. magnesium
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/805Pet food for dog, cat, bird, or fish

Definitions

  • the present invention relates to an animal feed composition and an animal product containing phlorotannin as an active ingredient having antioxidant and inflammation improving effects.
  • the composition and the animal product of the present invention have the function of giving shine to animal hair through antioxidative effect and inflammation improving effect, improving animal odor, color change, obesity, and contributing to psychological stability.
  • the present invention also relates to an animal feed composition and an animal product which can be safely and safely taken for a long period using a natural ingredient as a main ingredient.
  • companion animals are consuming excessive amounts of food and snacks and consuming human food, resulting in overweight or nutritional imbalance.
  • An increase in the weight of the animal stimulates the joints, and sustained stimulation can also lead to inflammatory diseases and degenerative arthritis.
  • the incidence of arthritis and inflammatory diseases can cause psychological anxiety during the lifetime of companion animals and can have a negative impact on companion animal emotions.
  • interest in degenerative diseases due to aging such as arthritis and dementia of companion animals is increasing among the pet animals, and interest in daily health care is also increasing.
  • Inflammation is caused by pathogens, stimulants, etc. It inhibits early cell damage and regenerates tissue. However, when inflammation becomes worse, it also causes diseases such as inflammatory diseases. Immune strengthening is needed to prevent inflammation from developing into disease, which means that normal nutrient intake and functional foods are needed. In addition, since animals can not express their intentions unlike humans, it is necessary to routinely treat foods that are usually taken, antioxidants in snacks, and functional foods with anti-inflammatory functions.
  • Korean prior art 10-1777842 discloses an animal feed
  • Korean Patent Laid-Open No. 10-2005-0099436 discloses an animal feed containing sea tangle added thereto, which comprises an antiallergic and anti- Containing animal feed additive.
  • the present invention provides a composition for animal feed containing fluorotannin having antioxidant and anti-inflammatory functions derived from brown algae, unlike the existing patent, and provides an animal product including the functional ingredient.
  • the present invention provides a composition for animal feed comprising an antioxidant, an anti-inflammatory function, and a product for animals, thereby improving the daily health care of animals and reducing the incidence of inflammatory diseases, We want to improve the satisfaction of the liver.
  • a composition for animal feed comprising an antioxidant, an anti-inflammatory function, and a product for animals, thereby improving the daily health care of animals and reducing the incidence of inflammatory diseases, We want to improve the satisfaction of the liver.
  • We also provide various kinds of products such as powdered products, animal feed, and snacks so that users can conveniently access and apply them.
  • the present invention provides a composition for animal feed comprising phlorotannin as an active ingredient.
  • the present invention also provides an animal product comprising said composition.
  • the present invention also provides a method of using a composition comprising phlorotannin as an active ingredient as an animal feed.
  • composition for animal feed containing the phlorotannin of the present invention as an active ingredient contains a naturally occurring material and does not contain a preservative or a chemical substance so that it can be used safely and has no concern about side effects and is applied in various forms such as feed and snack This is possible.
  • the product of the present invention is applied to a product that is routinely used to help an animal in daily health care and has an effect of improving immunity.
  • FIG. 1 is a diagram showing a product example 1 of the second embodiment.
  • Fig. 2 is a diagram showing a product example 2 of the third embodiment.
  • Fig. 3 is a graph showing the antioxidative effect of the composition 2.
  • 5 is a graph showing the effect of the composition 2 on PGE2 production inhibition.
  • Fig. 6 is a graph showing the effect of inhibiting COX-2 production of the composition 2.
  • the present invention provides a composition for animal feed having anti-inflammation and antioxidant activity, and has developed a product utilizing the composition, thereby completing the present invention.
  • the present invention provides a composition for animal feed comprising a phlorotannin compound as an active ingredient.
  • composition for animal feed containing the phlorotannin of the present invention as an active ingredient has an antioxidant and anti-inflammatory function and improves the health of animals.
  • the present invention provides a method of using a composition comprising phlorotannin as an active ingredient as an animal feed.
  • the composition improves the health of the animal by having antioxidant anti-inflammatory function.
  • the animal feed composition may contain 20 to 100% by weight of a float tannin compound.
  • composition for animal feed can be obtained by any conventional method as a naturally derived component. That is, they may be synthesized by using commercially available reagents or may be obtained by extracting and separating from natural products, particularly seaweeds.
  • the animal feed composition may be a seaweed extract.
  • the composition for animal feed can be a spirit extract of seaweed.
  • the composition for animal feed comprising the above phlorotannin as an active ingredient can be extracted from seaweeds, especially brown algae, and specifically includes Eisenia bicyclis, Eisenia arborea, Eisenia desmarestioides (Eisenia desmarestioides) Eisenia galapagensis, Eisenia masonii, Ecklonia kurome, Ecklonia cava, Ecklonia stolonifera, Ecklonia maxima, Ecklonia maxima, Ecklonia radiata, Ecklonia bicyclis, Ecklonia biruncinate, Ecklonia buccinalis, Ecklonia caepaestipes, Ecklonia spp., Ecklonia spp.
  • Eisenia bicyclis Eisenia arborea
  • Eisenia desmarestioides Eisenia galapagensis
  • Eisenia masonii Eisenlonia kurome
  • Ecklonia cava Ecklonia stolonifera
  • Ecklonia maxima Ecklonia maxima
  • Ecklonia exasperta Ecklonia fastigiata
  • Ecklonia brevipes Ecklonia brevipes
  • Ecklonia brevipes a group consisting of Ecklonia latifolia, Ecklonia muratii, Ecklonia radicosa, Ecklonia richardiana and Ecklonia wrightii)
  • composition of the present invention may further contain 0 to 80% by weight of a component composed of mannitol, alginic acid, fucoidan, laminaran, and fucosterol, fucosanthin and the like as lipid components.
  • composition for animal feed of the present invention may contain at least one selected from among the compounds represented by the following general formulas (1) to (12).
  • composition for animal feed of the present invention may contain at least one kind of phlorotannin selected from the group consisting of the above-mentioned formulas (2), (4), (5) and (8) When the proper amount of the fluorotannin is contained, the antioxidant and inflammation improving effect are excellent.
  • composition for animal feed according to the present invention preferably comprises 1 to 60% by weight of phlorotannin of formula (2), 0.3 to 20% by weight of phlorotannin of formula (4), 0.1 to 10% by weight of phlorotannin of formula And 0.1 to 5% by weight of a fluorotannine represented by the general formula (8).
  • the composition for animal feed according to the present invention comprises 0.1 to 3% by weight of phlorotannin of the formula (1), 5 to 63% by weight of the phlorotannin of the formula (2), 1 to 3% by weight of the phlorotannin of the formula
  • composition of the present invention comprises 20 to 100% by weight of phlorotannin, 0 to 30% by weight of mannitol, 0 to 25% by weight of alginic acid, 0 to 25% by weight of fucoidan, 0 to 10% by weight of fucosterol, 0 to 10% , And 0 to 10% by weight of laminaran.
  • composition of the present invention comprises less than 20 to less than 100% by weight of phlorotannin, greater than 0 to 30% by weight of mannitol, greater than 0 to 25% by weight of alginic acid, more than 0 to 25% by weight of fucoidan, more than 0 to 10% From more than 0 to 10% by weight, and from 0 to 10% by weight of laminaran.
  • composition for animal feed of the present invention may be in the form of powder or liquid for easy addition to products such as animal feed, animal snack, and the like.
  • the present invention provides an animal product comprising the composition for animal feed comprising the above-mentioned fluro tannin.
  • the animal product of the present invention can be used in combination with a composition for animal feed comprising phlorotannin and various auxiliary agents such as amino acids, inorganic salts, vitamins, antibiotics, antimicrobials, antioxidants, antifungals, enzymes, living microbial preparations and the like as auxiliary components; Cereals such as ground or crushed wheat, oats, barley, corn and rice; Vegetable proteins such as rapeseed, beans and sunflower; Animal proteins such as blood, meat, bone meal and fish meal; And various sugar and dairy products such as various powdered milk and whey powders.
  • auxiliary agents such as amino acids, inorganic salts, vitamins, antibiotics, antimicrobials, antioxidants, antifungals, enzymes, living microbial preparations and the like as auxiliary components
  • Cereals such as ground or crushed wheat, oats, barley, corn and rice
  • Vegetable proteins such as rapeseed, beans and sunflower
  • Animal proteins such as blood, meat, bone meal and fish
  • the animal product may contain 0.1 to 50% by weight, more preferably 0.2 to 10% by weight, of the composition for animal feed containing phlorotannin, based on the total weight of the product, but the blending amount is not limited to the above range.
  • the animal product of the present invention contains the animal feed composition in the above amount, it can provide the antioxidant, anti-inflammatory effect of the animal, improve the health care, and improve the immunity.
  • the present invention relates to a composition for animal feed comprising collagen, flaxseed extract, calcium, iron, vitamin B12 and vitamins such as vitamin E, copper, chicken, pig gelatin, rice flour, soy flour, wheat flour, minerals, , Glycerin, fish, and water.
  • the present invention also provides an animal product comprising at least one member selected from the group consisting of glycerin, fish and water
  • the product preferably contains 1 to 50% by weight of the animal feed composition of the present invention, 40 to 80% by weight of collagen, 1 to 4% by weight of flaxseed extract, 5 to 15% by weight of calcium, 0.1 to 0.8% by weight of iron, To 0.01% by weight of vitamin E, 0.1 to 0.3% by weight of vitamin E, and 0.05 to 0.1% by weight of copper.
  • the occurrence of inflammatory diseases of animals is alleviated and the animal's health is improved.
  • the animal product of the present invention can be commercialized as animal feed in powder or granular form, or snacks such as canned food and canned food.
  • the animal product of the present invention may contain 80-97% by weight of at least one member selected from the group consisting of chicken, pig gelatin, rice flour, soy flour and wheat flour. In this case, there is an advantage that it is easy to commercialize while providing balanced nutrition to animals.
  • the daily use amount of the phlorotannin contained in the animal product of the present invention is preferably about 0.1 to 100 mg, more preferably about 1 to 50 mg, but the dosage is not limited to the above range.
  • the brown algae were extracted from the brown algae by the following method.
  • Ecklonia cava was washed with distilled water to remove foreign matter, dried in shade, and then shattered.
  • 500 g of the above menthol was added to the extraction vessel, 20 times of 30 wt% aqueous solution of menthol was added thereto, and the mixture was refluxed for extraction at 75 to 80 ° C for 4 hours to obtain an extract.
  • the extract was filtered through a filter net of 10 mu m, and the filtered extract was concentrated under reduced pressure to obtain a primary extract concentrate.
  • the primary extract concentrate was dried with a vacuum drier and pulverized to obtain 170 g of Composition 1.
  • composition 1 was dissolved in hot water at 50 ⁇ , adsorbed on an adsorption resin, washed with water, and eluted with a solvent to obtain a fluorotannine eluant.
  • the eluate was filtered through a 1 ⁇ filter net, and the filtered extract was concentrated under reduced pressure to obtain a second extract concentrate.
  • the second extraction concentrate was dried with a vacuum drier and pulverized to obtain 30 g of Composition 2.
  • composition 2 was suspended in 20 times as much distilled water and extracted three times with the same amount of ethyl acetate solvent to obtain an ethyl acetate fraction.
  • the ethyl acetate fraction was concentrated under reduced pressure, and the concentrate was dried with a vacuum drier and pulverized to obtain 10 g of Composition 3
  • compositions 1 to 3 prepared above were loaded onto liquid chromatography to proceed with compound separation.
  • the compounds thus obtained were identified as the compounds of the formulas (1) to (12) using the NMR spectroscopic analysis apparatus.
  • the composition prepared above was dissolved in 60 vol% methanol, filtered through a 0.2 mu m membrane filter, and then the filtrate was loaded onto high performance liquid chromatography.
  • HP ODS Hypersil was used as the column, distilled water and methanol were used as the solvent, and the solvent was fed from a linear gradient of from 15 vol% to 70 vol% of methanol for 30 minutes at a flow rate of 1.0 ml / ).
  • the chemical compositions of the compositions 1 to 3 are shown in Table 1 below.
  • Example 1 Composition 1 20% by weight of total fluorotannine containing 2% by weight of the formula 2, 1% by weight of the formula 4, 0.5% by weight of the formula 5, 0.3% by weight of the formula 8 and 16.2% by weight of the single compound of the formula 1-12, , 20% by weight of alginic acid, 20% by weight of fucoidan, 5% by weight of fucosterol, 5% by weight of fucoxanthin, 5% Composition 2 70% by weight of total fluorotannine, 10% by weight of mannitol, 3% by weight of the compound of formula (2), 3% by weight of the compound of formula (4) , 6% by weight of alginic acid, 6% by weight of fucoidan, 3% by weight of fucosterol, 3% by weight of fucozanthin, 2% Composition 3 100% by weight of total fluorotannin including 17% by weight of Formula 2, 5% by weight of Formula 4, 5% by weight of Formula 5, 3% by weight of Formula 8, and 70%
  • Example 2 Preparation of Powdered Product Example 1 Using the Composition
  • Example 1 was prepared by adding collagen, flaxseed extract, calcium, iron powder, vitamin B12, vitamin E and copper to Composition 2 as an example of a powdered product using the composition of Example 1.
  • the composition of the product example 1 is shown in the following [Table 2].
  • the manufactured product example 1 is shown in Fig.
  • composition 2 Ingredients content(%) Composition 2 5 Colaken 75 Flaxseed extract 4 calcium 15 iron content 0.7 Vitamin B12 0.01 Vitamin E 0.2 Copper 0.09 Sum 100
  • Product Example 1 itself can be fed to animals and mixed with common feed. It can also be used easily with snacks such as canned foods and chicken breasts.
  • Product Example 2 Animal feeds (Product Example 2) were prepared by adding other raw materials to the above-mentioned Product Example 1, and the composition thereof is shown in Table 3 below.
  • Product Example 2 can be fed in the same manner as ordinary feeds. Feed amount is 1.5 ⁇ 3g per animal, 2.5 ⁇ 5g for animals less than 15 ⁇ 30kg and 5 ⁇ 7.5g for animals over 30kg. The prepared animal feed is shown in Fig.
  • the antioxidative effect of the composition of Example 1 was evaluated as follows.
  • composition 2 of Example 1 and vitamin C which is known to have antioxidative effects, were each dissolved in a 50% ethanol aqueous solution at a concentration of 1 mg / mL and then added to a DPPH (1,1-diphenyl-2-picrylhydrazyl) solution having an absorbance of 0.94 to 0.98 in a 10% And then allowed to stand for 10 minutes.
  • the absorbance is measured after 10 minutes to calculate the radical scavenging rate.
  • the method of calculating the radical scavenging rate is as follows.
  • Radical scavenging rate (%) (initial absorbance - absorbance after 10 minutes) / initial absorbance X 100
  • the macrophage cell line (RAW 264.7) in rats was treated with LPS (lipopolysaccharide) and the NO, PGE2 and COX-2 levels were measured to evaluate the anti-inflammatory effect.
  • LPS lipopolysaccharide
  • NO concentration was measured by incubating the cultured cells with the composition 2 of Example 1 (30 ⁇ 120 ⁇ g / mL) for 1 hour, followed by treatment with LPS to induce an inflammatory reaction. After 24 hours of LPS treatment, the culture solution was mixed with an equal amount of a Griess reagent and absorbance was measured at 530 nm. For the NO concentration calculation, a standard curve was created using the absorbance of NaNO 2 concentration, and the concentration was calculated.
  • the concentrations of PGE2 and COX-2 were measured using an enzyme-linked immunosorbent assay (ELISA assay).
  • ELISA assay enzyme-linked immunosorbent assay
  • the cell culture medium was inoculated into the enzyme-coupled immunosorbent kit one day after the treatment with LPS and the composition, and the absorbance was measured at 540 nm.
  • Concentrations of each protein were calculated by preparing a standard curve with a 4-PL logistic curve fit using absorbance results obtained by treating standard products in concentration-dependent manner.
  • the anti-inflammatory effect evaluation results are shown in [FIG. 4] to [FIG. 6].
  • the significance of the test results was confirmed by using T-test and P ⁇ 0.05 (* P ⁇ 0.05 vs control, P ⁇ 0.05 vs LPS).
  • composition of the present invention significantly alleviated the inflammatory reaction caused by LPS.
  • composition of the present invention when the composition of the present invention was treated with LPS in a mouse macrophage, the NO concentration was decreased, and the NO concentration was further decreased as the concentration was increased have. This means that the composition of the present invention reduces inflammation by inhibiting the production of NO, an inflammatory reaction product caused by LPS.
  • composition of the present invention when the composition of the present invention was treated with LPS in a mouse macrophage, the concentration of COX-2 decreased, and as the concentration increased, the concentration of COX-2 decreased further .
  • the composition of the present invention reduces inflammation by inhibiting the production of COX-2, an inflammatory response protein caused by LPS.
  • composition of the present invention when the composition of the present invention was treated with LPS in a mouse macrophage, the concentration of PGE2 decreased, and the concentration of PGE2 was further decreased as the concentration increased have. This means that the composition of the present invention suppresses inflammation by inhibiting the production of PGE2, an inflammatory response protein caused by LPS.
  • a sample prepared by taking 0.1 g of the powder of Product Example 1 in the form of a capsule and the sample of Product Example 2 were continuously fed to the experimental animals together with feed for one month.
  • the efficacy of the product samples was evaluated by evaluating the smell, color change, odor and hair gloss of the animals before and after the feeding.
  • the evaluation method was evaluated as 2 (bad), 4, 6, 8, 10 (good) using the 5-point scale.
  • For the objective test results only the animals that did not have any abnormality in health were selected and the experimental animals were opened. According to the weight of the experimental animals, in Example 1, 1 capsule was administered to animals less than 15 kg, 2 capsules for animals less than 15 to 30 kg, and 3 capsules for animals over 30 kg were fed twice a day.
  • the product examples 1 and 2 of the present invention improved the gloss, smell, odor, and color of the hairs of the fed animals.
  • Example 2 In order to evaluate the efficacy of the animal feed of Example 2 for improving obesity, 10 dogs that were overweight by 20% of their normal weight were selected and fed with the product Example 2 when they were fed. In Example 2, 1.5 g of the animal less than 15 kg, 2.5 g of the animal less than 15 to 30 kg, and 5 g of the animal more than 30 kg were fed twice a day, and the obesity improvement effect was evaluated by comparing the post- Respectively. For the objective test results, the animals were selected from the animals that had undergone growth, and those without obesity were selected. The overweight of the animals was calculated by the following formula using the standard weight per breed.
  • Overweight (%) (current weight - normal weight) / normal weight
  • the present invention uses a composition containing florotannin extracted from brown algae, which can be safely applied to animals, and can improve the gloss, odor, odor, color, and overweight of animal hair.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to a composition for animal feed having antioxidation and anti-inflammatory properties comprising phlorotannin extracted from brown algae and, particularly, to a composition and a product capable of safe applications on a daily basis by means of using raw materials of natural origins and having a function of improvements in the glossiness of fur, stench, odor of feces, color of the feces, and overweightedness.

Description

플로로탄닌을 유효성분으로 포함하는 동물사료용 조성물 및 동물용 제품Composition for animal feed comprising phlorotannin as an active ingredient and animal products
본 발명은 항산화, 염증개선 효과를 갖는 플로로탄닌을 유효성분으로 포함하는 동물사료용 조성물 및 동물용 제품에 관한 것이다. 본 발명의 조성물 및 동물용 제품은 항산화 효과, 염증 개선 효과 등을 통해 동물의 털에 윤기를 주며, 동물의 냄새, 변냄새, 변색깔, 비만을 개선하고, 심리적 안정에 기여하는 기능을 갖는다. 또한 본 발명은 천연성분을 주원료로 하여 안전하게 장기간 복용이 가능한 동물사료용 조성물 및 동물용 제품에 관한 것이다.The present invention relates to an animal feed composition and an animal product containing phlorotannin as an active ingredient having antioxidant and inflammation improving effects. The composition and the animal product of the present invention have the function of giving shine to animal hair through antioxidative effect and inflammation improving effect, improving animal odor, color change, obesity, and contributing to psychological stability. The present invention also relates to an animal feed composition and an animal product which can be safely and safely taken for a long period using a natural ingredient as a main ingredient.
1인 가정이 늘어나고 평균소득이 늘어나면서 반려동물을 키우는 가정이 늘어나고 있다. 반려동물의 개체 수 증가에 따라 관련 산업의 규모도 증가하고 있는데, 한국농촌경제원의 반려동물 사료산업 현황에 따르면 2012년 2,500억원 이던 사료산업 규모가 2016년 4,600억원으로 증가했다. 또한 반려동물을 키우는 가정의 인식개선을 통한 예방접종의 증가와 먹이의 질 개선을 통해 반려동물의 평균수명도 증가하는 추세이다. As one family increases and average income increases, more families are growing. As the number of companion animals increases, the size of the related industry is also increasing. According to the status of companion animal feed industry in Korea Rural Economic Institute, the feed industry, which was 250 billion won in 2012, increased to 460 billion won in 2016. In addition, the average lifespan of companion animals is also increasing due to the increase in vaccination and the improvement of food quality through the improvement of the awareness of the family raising the companion animal.
그러나 반려동물이 사료 및 간식을 과다섭취하고 사람이 먹는 음식물을 섭취하면서 과체중 또는 영양 불균형으로 인한 문제가 발생하고 있다. 동물의 체중의 증가는 관절에 자극을 주고 지속적인 자극은 염증성 질환 및 퇴행성 관절염을 일으키기도 한다. 관절염 및 염증성 질환의 발생은 반려동물의 생애기간동안 심리적 불안감을 유발하고, 반려동물주의 정서에도 나쁜 영향을 줄 수 있다. 그에 따라 반려동물주들 사이에서 반려동물의 관절염, 치매 등 노화로 인한 퇴행성 질환에 대한 관심이 높아지고 있으며, 일상건강관리 대한 관심도 늘어나고 있다.However, companion animals are consuming excessive amounts of food and snacks and consuming human food, resulting in overweight or nutritional imbalance. An increase in the weight of the animal stimulates the joints, and sustained stimulation can also lead to inflammatory diseases and degenerative arthritis. The incidence of arthritis and inflammatory diseases can cause psychological anxiety during the lifetime of companion animals and can have a negative impact on companion animal emotions. As a result, interest in degenerative diseases due to aging such as arthritis and dementia of companion animals is increasing among the pet animals, and interest in daily health care is also increasing.
염증은 병원균, 자극원 등에 의해 발생하며 초기세포손상의 억제 및 조직재생 등의 기능을 하지만 염증이 심해지면 염증성 질환과 같은 병을 유발하기도 한다. 염증이 질환으로 발전하는 것을 막기 위해 면역력 강화가 필요한데 이는 평소 영양분섭취 및 기능성 식품이 필요함을 의미한다. 또한 동물의 경우 사람과 달리 의사표현이 불가능하므로 평소 섭취하는 사료, 간식에 항산화, 항염증 기능이 있는 기능성 식품을 투여하는 일상적 처치가 필요하다.Inflammation is caused by pathogens, stimulants, etc. It inhibits early cell damage and regenerates tissue. However, when inflammation becomes worse, it also causes diseases such as inflammatory diseases. Immune strengthening is needed to prevent inflammation from developing into disease, which means that normal nutrient intake and functional foods are needed. In addition, since animals can not express their intentions unlike humans, it is necessary to routinely treat foods that are usually taken, antioxidants in snacks, and functional foods with anti-inflammatory functions.
동물사료에 대한 기존의 선행기술을 살펴보면 대한민국 등록특허 제10-1777842에 따르면 다시마를 첨가한 동물사료를 제공하고, 대한민국 공개특허 제10-2005-0099436은 항알러지 및 항염증 활성을 갖는 다래 추출물을 함유한 동물사료 첨가제를 제공한다. Korean prior art 10-1777842 discloses an animal feed, and Korean Patent Laid-Open No. 10-2005-0099436 discloses an animal feed containing sea tangle added thereto, which comprises an antiallergic and anti- Containing animal feed additive.
본 발명에서는 기존의 특허와 달리 갈조류 유래로 항산화, 항염증 기능을 갖는 플로로탄닌을 포함하는 동물사료용 조성물을 제공하고, 상기 기능성원료를 포함한 동물용 제품을 제공하고자 한다.The present invention provides a composition for animal feed containing fluorotannin having antioxidant and anti-inflammatory functions derived from brown algae, unlike the existing patent, and provides an animal product including the functional ingredient.
본 발명은 항산화, 항염증 기능을 갖는 플로로탄닌을 유효성분으로 하는 동물 사료용 조성물 및 동물을 위한 제품을 제공함으로써, 동물의 일상적인 건강관리에 도움을 주고 염증성 질환의 발생을 경감시켜 동물의 생애간 만족감을 증진시키고자 한다. 또한 분말형 제품, 동물사료, 간식 등 여러 종류의 제품을 제공하여 사용자가 편리하게 접근 및 적용할 수 있도록 하고자 한다.The present invention provides a composition for animal feed comprising an antioxidant, an anti-inflammatory function, and a product for animals, thereby improving the daily health care of animals and reducing the incidence of inflammatory diseases, We want to improve the satisfaction of the liver. We also provide various kinds of products such as powdered products, animal feed, and snacks so that users can conveniently access and apply them.
상기의 목적을 달성하기 위해 본 발명은 플로로탄닌을 유효성분으로 포함하는 동물 사료용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for animal feed comprising phlorotannin as an active ingredient.
또한 본 발명은 상기 조성물을 포함하는 동물용 제품을 제공한다.The present invention also provides an animal product comprising said composition.
또한 본 발명은 플로로탄닌을 유효성분으로 포함하는 조성물을 동물사료로 사용하는 방법을 제공한다.The present invention also provides a method of using a composition comprising phlorotannin as an active ingredient as an animal feed.
본 발명의 플로로탄닌을 유효성분으로 함유한 동물 사료용 조성물은 천연에 존재하는 소재를 포함하고 방부제 또는 화학물질을 포함하지 않아서 안전하게 사용이 가능하고 부작용의 염려가 없으며 사료, 간식 등 여러 형태로 적용이 가능하다. 또한 본 발명의 제품은 일상적으로 사용하는 제품에 적용하여 동물의 평소 건강관리에 도움을 주며 면역력을 증진시키기는 효과가 있다.The composition for animal feed containing the phlorotannin of the present invention as an active ingredient contains a naturally occurring material and does not contain a preservative or a chemical substance so that it can be used safely and has no concern about side effects and is applied in various forms such as feed and snack This is possible. In addition, the product of the present invention is applied to a product that is routinely used to help an animal in daily health care and has an effect of improving immunity.
도 1은 실시예 2의 제품예 1을 나타낸 도이다.BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a diagram showing a product example 1 of the second embodiment. Fig.
도 2는 실시예 3의 제품예 2를 나타낸 도이다.Fig. 2 is a diagram showing a product example 2 of the third embodiment. Fig.
도 3은 조성물 2의 항산화 효과를 나타낸 도이다.Fig. 3 is a graph showing the antioxidative effect of the composition 2. Fig.
도 4은 조성물 2의 NO생성 억제 효과를 나타낸 도이다.4 is a graph showing the NO generation inhibiting effect of Composition 2;
도 5는 조성물 2의 PGE2생성 억제 효과를 나타낸 도이다.5 is a graph showing the effect of the composition 2 on PGE2 production inhibition.
도 6은 조성물 2의 COX-2생성 억제 효과를 나타낸 도이다.Fig. 6 is a graph showing the effect of inhibiting COX-2 production of the composition 2. Fig.
이하 본 발명에 대하여 상세히 설명한다.Hereinafter, the present invention will be described in detail.
1인 가정이 늘어나며 반려동물을 키우는 가구의 수가 늘고 있고, 반려동물용 사료 및 의약품의 발달로 생존연령이 길어져 노령의 반려동물의 건강관리에 대한 문제가 대두되고 있다. 노령 반려동물에서 발생하는 관절염, 구내염, 치매 등 퇴행성 및 염증성 질병은 생애간 불편함을 유발하고 반려동물을 기우는 사람의 정서에도 악영향을 줄 수 있다. 또한 반려동물의 불규칙한 영양공급으로 유발되는 비만 및 영양불균형은 동물의 건강을 악화시킬 수 있다.The number of households with one person is increasing, the number of households raising their companion animals is increasing, and due to the development of feed and medicine for companion animals, the survival age is getting longer and the problem of health care of aged companion animals is emerging. Degenerative and inflammatory diseases such as arthritis, stomatitis, and dementia that occur in aged companion animals can cause life-style inconvenience and adversely affect people's emotions. Obesity and nutritional imbalance caused by irregular nutrition of companion animals may also exacerbate the health of animals.
따라서 본 발명에서는 항염증, 항산화 활성이 있는 동물 사료용 조성물을 제공하고 그 조성물을 활용한 제품을 개발함으로써 본 발명을 완성하였다.Accordingly, the present invention provides a composition for animal feed having anti-inflammation and antioxidant activity, and has developed a product utilizing the composition, thereby completing the present invention.
본 발명은 플로로탄닌 화합물을 유효성분으로 포함하는 동물사료용 조성물을 제공한다.The present invention provides a composition for animal feed comprising a phlorotannin compound as an active ingredient.
본 발명의 플로로탄닌을 유효성분으로 포함하는 동물사료용 조성물은 항산화, 항염증 기능을 해 동물의 건강을 개선한다.The composition for animal feed containing the phlorotannin of the present invention as an active ingredient has an antioxidant and anti-inflammatory function and improves the health of animals.
본 발명은 플로로탄닌을 유효성분으로 포함하는 조성물을 동물사료로 사용하는 방법을 제공한다. 상기 조성물을 사료로 사용하는 경우 조성물은 항산화 항염증 기능을 함으로서 동물의 건강을 개선한다.The present invention provides a method of using a composition comprising phlorotannin as an active ingredient as an animal feed. When the composition is used as a feed, the composition improves the health of the animal by having antioxidant anti-inflammatory function.
상기 동물사료용 조성물은 플로로탄닌 화합물을 20 ~ 100 중량% 포함할 수 있다.The animal feed composition may contain 20 to 100% by weight of a float tannin compound.
상기 동물사료용 조성물은 천연유래 성분으로 통상적인 모든 방법에 의해 얻을 수 있다. 즉, 시판되는 시약을 사용하여 합성할 수도 있으며 천연물, 특히 해조류로부터 추출 및 분리하여 얻을수도 있다.The composition for animal feed can be obtained by any conventional method as a naturally derived component. That is, they may be synthesized by using commercially available reagents or may be obtained by extracting and separating from natural products, particularly seaweeds.
상기 동물사료용 조성물은 해조류 추출물일 수 있다. 상기 동물사료용 조성물은 해조류의 주정 추출물일 수 있다.The animal feed composition may be a seaweed extract. The composition for animal feed can be a spirit extract of seaweed.
상기 플로로탄닌을 유효성분으로 하는 동물사료용 조성물은 해조류, 특히 갈조류에서 추출할 수 있으며 구체적으로 대황(Eisenia bicyclis), 아이세니아 아르보레아(Eisenia arborea), 아이세니아 데스마레스티오데스(Eisenia desmarestioides), 아이세니아 갈라파제니스(Eisenia galapagensis), 아이세니아 매소니(Eisenia masonii), 검둥감태(Ecklonia kurome), 감태(Ecklonia cava), 곰피(Ecklonia stolonifera), 바다대나무(Ecklonia maxima), 에클로니아 라디아타(Ecklonia radiata), 에클로니아 바이시클리스(Ecklonia bicyclis), 에클로니아 바이런시네이트(Ecklonia biruncinate), 에클로니아 부시날리스(Ecklonia buccinalis), 에클로니아 카에파에스팁스(Ecklonia caepaestipes), 에클로니아 엑사스퍼타(Ecklonia exasperta), 에클로니아 파스티기아타(Ecklonia fastigiata), 에클로니아 브레빕스(Ecklonia brevipes), 에클로니아 아라보레아(Ecklonia arborea), 에클로니아 라티폴리아(Ecklonia latifolia), 에클로니아 무라티(Ecklonia muratii), 에클로니아 라디코사(Ecklonia radicosa), 에클로니아 리타디아나(Ecklonia richardiana) 및 에클로니아 라이티(Ecklonia wrightii)로 이루어진 그룹으로부터 선택된 1종 이상의 해조류로부터 추출될 수 있다.The composition for animal feed comprising the above phlorotannin as an active ingredient can be extracted from seaweeds, especially brown algae, and specifically includes Eisenia bicyclis, Eisenia arborea, Eisenia desmarestioides (Eisenia desmarestioides) Eisenia galapagensis, Eisenia masonii, Ecklonia kurome, Ecklonia cava, Ecklonia stolonifera, Ecklonia maxima, Ecklonia maxima, Ecklonia radiata, Ecklonia bicyclis, Ecklonia biruncinate, Ecklonia buccinalis, Ecklonia caepaestipes, Ecklonia spp., Ecklonia spp. Ecklonia exasperta, Ecklonia fastigiata, Ecklonia brevipes, Ecklonia brevipes, a group consisting of Ecklonia latifolia, Ecklonia muratii, Ecklonia radicosa, Ecklonia richardiana and Ecklonia wrightii), a group consisting of Arborea, Arborea, Ecklonia latifolia, Ecklonia muratii, Ecklonia radicosa, Ecklonia richardiana and Ecklonia wrightii ≪ / RTI >
본 발명의 조성물은 플로로탄닌 외에 탄수화물 성분으로서 만니톨, 알긴산, 푸코이단, 라미나란 및 지질 성분으로서 푸코스테롤, 푸코잔틴 등으로 구성되는 성분을 추가적으로 0-80중량% 함유할 수 있다.In addition to phlorotannin, the composition of the present invention may further contain 0 to 80% by weight of a component composed of mannitol, alginic acid, fucoidan, laminaran, and fucosterol, fucosanthin and the like as lipid components.
본 발명의 동물사료용 조성물은 하기 화학식 1 ~ 화학식 12로 표시되는 화합물 중 선택되는 1종 이상의 플로로탄닌을 포함할 수 있다.The composition for animal feed of the present invention may contain at least one selected from among the compounds represented by the following general formulas (1) to (12).
[화학식 1][Chemical Formula 1]
Figure PCTKR2019001025-appb-I000001
Figure PCTKR2019001025-appb-I000001
[화학식 2](2)
Figure PCTKR2019001025-appb-I000002
Figure PCTKR2019001025-appb-I000002
[화학식 3](3)
Figure PCTKR2019001025-appb-I000003
Figure PCTKR2019001025-appb-I000003
[화학식 4][Chemical Formula 4]
Figure PCTKR2019001025-appb-I000004
Figure PCTKR2019001025-appb-I000004
[화학식 5][Chemical Formula 5]
Figure PCTKR2019001025-appb-I000005
Figure PCTKR2019001025-appb-I000005
[화학식 6][Chemical Formula 6]
Figure PCTKR2019001025-appb-I000006
Figure PCTKR2019001025-appb-I000006
[화학식 7](7)
Figure PCTKR2019001025-appb-I000007
Figure PCTKR2019001025-appb-I000007
[화학식 8][Chemical Formula 8]
Figure PCTKR2019001025-appb-I000008
Figure PCTKR2019001025-appb-I000008
[화학식 9][Chemical Formula 9]
Figure PCTKR2019001025-appb-I000009
Figure PCTKR2019001025-appb-I000009
[화학식 10][Chemical formula 10]
Figure PCTKR2019001025-appb-I000010
Figure PCTKR2019001025-appb-I000010
[화학식 11](11)
Figure PCTKR2019001025-appb-I000011
Figure PCTKR2019001025-appb-I000011
[화학식 12][Chemical Formula 12]
Figure PCTKR2019001025-appb-I000012
Figure PCTKR2019001025-appb-I000012
본 발명의 동물사료용 조성물은 유효성분으로 상기 화학식 2, 화학식 4, 화학식 5 및 화학식 8로 이루어진 그룹에서 선택되는 1종 이상의 플로로탄닌을 포함할 수 있다. 상기 플로로탄닌을 적정량 포함하는 경우 항산화 및 염증 개선 효과 등이 우수하다.The composition for animal feed of the present invention may contain at least one kind of phlorotannin selected from the group consisting of the above-mentioned formulas (2), (4), (5) and (8) When the proper amount of the fluorotannin is contained, the antioxidant and inflammation improving effect are excellent.
본 발명의 동물사료용 조성물은 전체중량에 대하여 바람직하게는 화학식 2의 플로로탄닌 1 내지 60중량%, 화학식 4의 플로로탄닌 0.3 내지 20중량%, 화학식 5의 플로로탄닌 0.1 내지 10중량% 또는 화학식 8의 플로로탄닌 0.1 내지 5중량%를 포함할 수 있다.The composition for animal feed according to the present invention preferably comprises 1 to 60% by weight of phlorotannin of formula (2), 0.3 to 20% by weight of phlorotannin of formula (4), 0.1 to 10% by weight of phlorotannin of formula And 0.1 to 5% by weight of a fluorotannine represented by the general formula (8).
본발명의 동물사료용 조성물은 전체 중량에 대하여 화학식 1의 플로로탄닌 0.1 ~ 3중량%, 화학식 2의 플로로탄닌 5 ~ 63중량%, 화학식 3의 플로로탄닌 1 ~ 3중량%, 화학식 4의 플로로탄닌 0.5 ~ 34중량%, 화학식 5의 플로로탄닌 0.1 ~ 50중량%, 화학식 6의 플로로탄닌 0.5 ~ 8중량%, 화학식 7의 플로로탄닌 0.1 ~ 1중량%, 화학식 8의 플로로탄닌 0.1 ~ 46중량%, 화학식 9의 플로로탄닌 0.1 ~ 2중량%, 화학식 10의 플로로탄닌 0.1 ~ 7중량%, 화학식 11의 플로로탄닌 0.1 ~ 3중량% 및 화학식 12의 플로로탄닌 0.1 ~ 4중량%를 포함할 수 있다.The composition for animal feed according to the present invention comprises 0.1 to 3% by weight of phlorotannin of the formula (1), 5 to 63% by weight of the phlorotannin of the formula (2), 1 to 3% by weight of the phlorotannin of the formula A fluorotannine represented by the following general formula (6): 0.5 to 8 wt%, a fluorotannine represented by the following general formula (7): 0.1 to 1 wt% 0.1 to 3% by weight of tannin, 0.1 to 3% by weight of tannin, 0.1 to 2% by weight of tannin, 0.1 to 2% by weight of a fluorotannine of the formula To 4% by weight.
본 발명의 조성물은 플로로탄닌 20~100중량%, 만니톨 0 내지 30 중량%, 알긴산 0 내지 25 중량%, 푸코이단 0 내지 25 중량%, 푸코스테롤 0 내지 10 중량%, 푸코잔틴 0 내지 10 중량%, 라미나란 0 내지 10 중량%을 포함할 수 있다.The composition of the present invention comprises 20 to 100% by weight of phlorotannin, 0 to 30% by weight of mannitol, 0 to 25% by weight of alginic acid, 0 to 25% by weight of fucoidan, 0 to 10% by weight of fucosterol, 0 to 10% , And 0 to 10% by weight of laminaran.
본 발명의 조성물은 플로로탄닌 20 내지100중량%미만, 만니톨 0 초과 내지 30 중량%, 알긴산 0 초과 내지 25 중량%, 푸코이단 0 초과 내지 25 중량%, 푸코스테롤 0 초과 내지 10 중량%, 푸코잔틴 0 초과 내지 10 중량%, 라미나란 0 초과 내지 10 중량%을 포함할 수 있다.The composition of the present invention comprises less than 20 to less than 100% by weight of phlorotannin, greater than 0 to 30% by weight of mannitol, greater than 0 to 25% by weight of alginic acid, more than 0 to 25% by weight of fucoidan, more than 0 to 10% From more than 0 to 10% by weight, and from 0 to 10% by weight of laminaran.
본 발명의 동물사료용 조성물은 동물사료, 동물간식 등의 제품에 첨가하기 용이하게 하기 위하여 분말 또는 액상의 형태일 수 있다.The composition for animal feed of the present invention may be in the form of powder or liquid for easy addition to products such as animal feed, animal snack, and the like.
본 발명은 상기 플로로탄닌을 포함하는 동물 사료용 조성물을 포함하는 동물용 제품을 제공한다.The present invention provides an animal product comprising the composition for animal feed comprising the above-mentioned fluro tannin.
본 발명의 동물용 제품은 플로로탄닌을 포함하는 동물사료용 조성물과 함께 보조성분으로 아미노산, 무기염류, 비타민, 항생물질, 항균물질, 항산화, 항곰팡이, 효소, 살아있는 미생물 제제 등과 같은 각종 보조제; 분쇄 또는 파쇄된 밀, 귀리, 보리, 옥수수 및 쌀과 같은 곡물; 평지, 콩 및 해바라기 같은 식물성 단백질; 혈분, 육분, 골분 및 생선분 같은 동물성 단백질; 각종 분유 및 유장 분말과 같은 당분 및 유제품을 포함할 수 있다. The animal product of the present invention can be used in combination with a composition for animal feed comprising phlorotannin and various auxiliary agents such as amino acids, inorganic salts, vitamins, antibiotics, antimicrobials, antioxidants, antifungals, enzymes, living microbial preparations and the like as auxiliary components; Cereals such as ground or crushed wheat, oats, barley, corn and rice; Vegetable proteins such as rapeseed, beans and sunflower; Animal proteins such as blood, meat, bone meal and fish meal; And various sugar and dairy products such as various powdered milk and whey powders.
상기 동물용 제품은 플로로탄닌 포함 동물사료용 조성물을 제품 총 중량대비 바람직하게는 0.1 ~ 50중량% 더욱 바람직하게는 0.2~10중량% 포함할 수 있으나, 배합량이 상기의 범위에 한정되는 것은 아니다. 본 발명의 동물용 제품이 동물사료용 조성물을 상기 함량으로 포함할 경우 동물의 항산화 효과 항염증 효과를 줄 수 있고 건강관리에 도움을 주며 면역력을 증진시킬 수 있다.The animal product may contain 0.1 to 50% by weight, more preferably 0.2 to 10% by weight, of the composition for animal feed containing phlorotannin, based on the total weight of the product, but the blending amount is not limited to the above range. When the animal product of the present invention contains the animal feed composition in the above amount, it can provide the antioxidant, anti-inflammatory effect of the animal, improve the health care, and improve the immunity.
본 발명은 상기 동물사료용 조성물과 함께 콜라겐, 아마씨추출물, 칼슘, 철분, 비타민 B12, 비타민 E 등의 비타민, 구리, 치킨, 피그젤라틴, 쌀가루, 콩가루, 밀가루, 미네랄, 치킨오일, 소비톨, 프로필렌글리콜, 글리세린, 생선 및 물을 포함하는 그룹으로부터 선택되는 1종 이상을 포함하는 동물용 제품을 제공한다The present invention relates to a composition for animal feed comprising collagen, flaxseed extract, calcium, iron, vitamin B12 and vitamins such as vitamin E, copper, chicken, pig gelatin, rice flour, soy flour, wheat flour, minerals, , Glycerin, fish, and water. The present invention also provides an animal product comprising at least one member selected from the group consisting of glycerin, fish and water
상기 제품은 바람직하게는 본 발명의 동물사료용 조성물 1 ~ 50중량%와 콜라겐 40 ~ 80중량%, 아마씨추출물 1 ~ 4중량%, 칼슘 5 ~ 15중량%, 철분 0.1 ~ 0.8중량%, 비타민 B12 0.008 ~ 0.01중량%, 비타민 E 0.1 ~ 0.3중량% 및 구리 0.05 ~ 0.1중량%를 포함할 수 있다. 이 경우 동물의 염증성 질환의 발생을 경감시키고 동물의 건강이 증진되는 효과가 있다.The product preferably contains 1 to 50% by weight of the animal feed composition of the present invention, 40 to 80% by weight of collagen, 1 to 4% by weight of flaxseed extract, 5 to 15% by weight of calcium, 0.1 to 0.8% by weight of iron, To 0.01% by weight of vitamin E, 0.1 to 0.3% by weight of vitamin E, and 0.05 to 0.1% by weight of copper. In this case, the occurrence of inflammatory diseases of animals is alleviated and the animal's health is improved.
본 발명의 동물용 제품은 분말 또는 입상형태의 동물용 사료, 또는 개껌과 통조림과 같은 간식 등으로 제품화될 수 있다.The animal product of the present invention can be commercialized as animal feed in powder or granular form, or snacks such as canned food and canned food.
본 발명의 동물용 제품은 치킨, 피그젤라틴, 쌀가루, 콩가루 및 밀가루로 이루진 그룹으로부터 선택되는 1종이상을 80~97중량% 포함할 수 있다. 이 경우 동물에게 균형있는 영양식을 제공하면서 제품화가 용이하다는 장점이 있다.The animal product of the present invention may contain 80-97% by weight of at least one member selected from the group consisting of chicken, pig gelatin, rice flour, soy flour and wheat flour. In this case, there is an advantage that it is easy to commercialize while providing balanced nutrition to animals.
본 발명의 동물용 제품에 포함되는 플로로탄닌의 1일 사용량은 바람직하게는 0.1 내지 100 mg, 더욱 바람직하게는 1 내지 50mg 정도이나 사용량이 상기의 범위에 한정되는 것은 아니다.The daily use amount of the phlorotannin contained in the animal product of the present invention is preferably about 0.1 to 100 mg, more preferably about 1 to 50 mg, but the dosage is not limited to the above range.
이하에서 실시예 및 실험예를 통하여 본 발명을 보다 상세히 설명한다. 그러나 하기의 실시예 및 실험예는 본 발명을 더욱 구체적으로 설명하기 위한 것으로서, 본 발명의 범위가 하기의 실시예 및 실험예에 의하여 한정되는 것은 아니다. 하기의 실시예 및 실험예는 본 발명의 범위 내에서 당업자에 의해 적절히 수정, 변경될 수 있다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples. However, the following examples and experimental examples are intended to further illustrate the present invention, and the scope of the present invention is not limited by the following examples and experimental examples. The following Examples and Experiments are appropriately modified and changed by those skilled in the art within the scope of the present invention.
실시예 1. 플로로탄닌을 함유한 조성물의 제조Example 1. Preparation of a composition containing fluorotannine
본 발명의 플로로탄닌을 유효성분으로 하는 동물사료용 조성물을 제조하기 위하여 국내산 갈조류로부터 하기의 방법으로 추출하였다.In order to prepare an animal feed composition containing the phlorotannin of the present invention as an active ingredient, the brown algae were extracted from the brown algae by the following method.
감태(Ecklonia cava)를 증류수로 세척하여 이물질을 제거하고 음지에서 건조한 후, 이를 파쇄하였다. 추출용기에 상기 감태 500g을 담았으며, 상기 감태 중량 대비 20배의 30 중량% 주정 수용액을 첨가하고, 75 ~ 80℃에서 4시간 동안 환류 추출하여 추출액을 얻었다. 상기 추출액을 10㎛의 여과망에 여과하고, 여과된 추출물을 감압 농축하여 1차 추출농축액을 얻었다. 상기 1차 추출농축액을 진공건조기로 건조한 후, 분쇄하여 조성물 1을 170g 얻었다. Ecklonia cava was washed with distilled water to remove foreign matter, dried in shade, and then shattered. 500 g of the above menthol was added to the extraction vessel, 20 times of 30 wt% aqueous solution of menthol was added thereto, and the mixture was refluxed for extraction at 75 to 80 ° C for 4 hours to obtain an extract. The extract was filtered through a filter net of 10 mu m, and the filtered extract was concentrated under reduced pressure to obtain a primary extract concentrate. The primary extract concentrate was dried with a vacuum drier and pulverized to obtain 170 g of Composition 1.
상기 조성물 1을 50℃의 온수에 용해한 뒤, 흡착수지에 흡착시킨 후, 물로 세척하고 주정으로 용출하여 플로로탄닌 용출액을 얻었다. 상기 용출액을 1㎛의 여과망에 여과하고, 여과된 추출물을 감압 농축하여 2차 추출농축액을 얻었다. 상기 2차 추출농축액을 진공건조기로 건조한 후, 분쇄하여 조성물 2를 30g 얻었다. The composition 1 was dissolved in hot water at 50 캜, adsorbed on an adsorption resin, washed with water, and eluted with a solvent to obtain a fluorotannine eluant. The eluate was filtered through a 1 탆 filter net, and the filtered extract was concentrated under reduced pressure to obtain a second extract concentrate. The second extraction concentrate was dried with a vacuum drier and pulverized to obtain 30 g of Composition 2.
이후 조성물 2를 20배량의 증류수에 현탁하고, 동일량의 에틸아세테이트 용매로 3회 추출하여 에틸아세테이트 분획을 얻었다. 상기 에틸아세테이트 분획을 감압 농축하고, 이 농축액을 진공건조기로 건조한 후, 분쇄하여 조성물 3을 10g 얻었다Then, the composition 2 was suspended in 20 times as much distilled water and extracted three times with the same amount of ethyl acetate solvent to obtain an ethyl acetate fraction. The ethyl acetate fraction was concentrated under reduced pressure, and the concentrate was dried with a vacuum drier and pulverized to obtain 10 g of Composition 3
상기에서 제조한 조성물 1 ~ 3에 대하여 액체 크로마토그래피에 로딩(loading)하여 화합물 분리를 진행하였다. 이때 얻어진 화합물은 화학식 1 내지 12의 화합물임을 화합물 구조분석 장치 NMR을 이용하여 확인하였다. 상기에서 제조한 조성물에 대하여 60부피% 메탄올에 용해시킨 후 0.2㎛ 막여과지로 여과한 후, 여과액을 고속 액체 크로마토그래피에 로딩(loading)하였다. 고속 액체 크로마토그래피에서, 컬럼은 HP ODS Hypersil, 용매는 증류수와 메탄올을 사용하였으며, 용매의 공급은 1.0㎖/분의 유속으로 메탄올 15부피%에서 70부피%까지 30분간에 걸쳐 선형구배(linear gradient)를 걸어 분석한 결과, 상기 화학식 1 내지 12의 화합물의 존재를 확인하였다. 상기 조성물 1 내지 3의 화학적 조성을 하기 [표 1]에 나타내었다.The compositions 1 to 3 prepared above were loaded onto liquid chromatography to proceed with compound separation. The compounds thus obtained were identified as the compounds of the formulas (1) to (12) using the NMR spectroscopic analysis apparatus. The composition prepared above was dissolved in 60 vol% methanol, filtered through a 0.2 mu m membrane filter, and then the filtrate was loaded onto high performance liquid chromatography. In high performance liquid chromatography, HP ODS Hypersil was used as the column, distilled water and methanol were used as the solvent, and the solvent was fed from a linear gradient of from 15 vol% to 70 vol% of methanol for 30 minutes at a flow rate of 1.0 ml / ). As a result, the presence of the compounds of Formulas 1 to 12 was confirmed. The chemical compositions of the compositions 1 to 3 are shown in Table 1 below.
시료sample 실시예 1Example 1
조성물 1Composition 1 화학식 2 2중량%, 화학식 4 1중량%, 화학식 5 0.5 중량%, 화학식 8 0.3 중량%, 그 외 화학식 1-12의 단일물을 16.2 중량%를 포함하는 총 플로로탄닌 20중량%, 만니톨 25 중량%, 알긴산 20 중량%, 푸코이단 20 중량%, 푸코스테롤 5 중량%, 푸코잔틴 5 중량%, 라미나란 5 중량%20% by weight of total fluorotannine containing 2% by weight of the formula 2, 1% by weight of the formula 4, 0.5% by weight of the formula 5, 0.3% by weight of the formula 8 and 16.2% by weight of the single compound of the formula 1-12, , 20% by weight of alginic acid, 20% by weight of fucoidan, 5% by weight of fucosterol, 5% by weight of fucoxanthin, 5%
조성물 2Composition 2 화학식 2 10 중량%, 화학식 4 3 중량%, 화학식 5 1중량%, 화학식 8 1.5중량%, 그 외 화학식 1-12의 단일물 54.5 중량%를 포함하는 총 플로로탄닌 70중량%, 만니톨 10 중량%, 알긴산 6 중량%, 푸코이단 6 중량%, 푸코스테롤 3 중량%, 푸코잔틴 3 중량%, 라미나란 2 중량%70% by weight of total fluorotannine, 10% by weight of mannitol, 3% by weight of the compound of formula (2), 3% by weight of the compound of formula (4) , 6% by weight of alginic acid, 6% by weight of fucoidan, 3% by weight of fucosterol, 3% by weight of fucozanthin, 2%
조성물 3Composition 3 화학식 2 17 중량%, 화학식 4 5 중량%, 화학식 5 5 중량%, 화학식 8 3 중량%, 그 외 화학식 1-12의 단일물 70 중량%를 포함하는 총 플로로탄닌 100중량%100% by weight of total fluorotannin including 17% by weight of Formula 2, 5% by weight of Formula 4, 5% by weight of Formula 5, 3% by weight of Formula 8, and 70%
실시예 2. 조성물을 활용한 분말형 제품예 1의 제조Example 2. Preparation of Powdered Product Example 1 Using the Composition
실시예 1의 조성물을 활용한 분말형 제품의 일예로, 조성물 2에 콜라겐, 아마씨추출물, 칼슘, 철분, 비타민 B12, 비타민 E, 구리를 배합하여 제품예 1을 제조하였다. 제품예 1의 조성은 아래의 [표 2]와 같다. 제조된 제품예 1을 [도 1]에 나타내었다.Example 1 was prepared by adding collagen, flaxseed extract, calcium, iron powder, vitamin B12, vitamin E and copper to Composition 2 as an example of a powdered product using the composition of Example 1. The composition of the product example 1 is shown in the following [Table 2]. The manufactured product example 1 is shown in Fig.
성분명Ingredients 함량(%)content(%)
조성물 2 Composition 2 55
콜라켄Colaken 7575
아마씨추출물Flaxseed extract 44
칼슘calcium 1515
철분iron content 0.70.7
비타민 B12Vitamin B12 0.010.01
비타민 EVitamin E 0.20.2
구리Copper 0.090.09
합 계 Sum 100100
제품예 1은 그 자체로도 동물에게 급여가 가능하고, 일반사료와 섞어 사용할 수도 있다. 또한 통조림, 닭가슴살 등의 간식과 섞어서도 간편하게 사용이 가능하다.Product Example 1 itself can be fed to animals and mixed with common feed. It can also be used easily with snacks such as canned foods and chicken breasts.
실시예 3. 제품예 2의 제조Example 3 Preparation of Product Example 2
상기 제품예 1에 다른 원료를 첨가하여 동물사료를 제조(제품예 2) 하였으며 그 조성은 아래의 [표 3]과 같다. 제품예 2는 일반사료와 같이 급여가 가능하며 급여량은 체중 15kg 미만의 동물은 1회당 1.5 ~ 3g, 15 ~ 30kg 미만의 동물은 2.5 ~ 5g, 30kg이상의 동물은 5 ~ 7.5g이 적절하다. 제조된 동물사료를 [도 2]에 나타내었다.Animal feeds (Product Example 2) were prepared by adding other raw materials to the above-mentioned Product Example 1, and the composition thereof is shown in Table 3 below. Product Example 2 can be fed in the same manner as ordinary feeds. Feed amount is 1.5 ~ 3g per animal, 2.5 ~ 5g for animals less than 15 ~ 30kg and 5 ~ 7.5g for animals over 30kg. The prepared animal feed is shown in Fig.
성분명Ingredients 함량(%)content(%)
제품예 1Product Example 1 88
하이드롤라이즈 치킨Hydrolyzed chicken 66
피그젤라틴Pig gelatin 55
쌀가루Rice flour 3333
콩가루Soybean flour 1515
밀가루flour 44
비타민, 미네랄Vitamins, minerals 0.10.1
치킨오일 Chicken oil 33
소비톨, 프로필렌글리콜Sorbitol, propylene glycol 17.317.3
글리세린glycerin 2.62.6
생선 fish 22
water 44
합 계 Sum 100100
실험예 1. 조성물의 항산화 효과 평가 실험Experimental Example 1. Evaluation of antioxidative effect of composition
실시예 1의 조성물의 항산화 효과를 다음과 같이 평가하였다.The antioxidative effect of the composition of Example 1 was evaluated as follows.
실시예 1의 조성물 2와 항산화 효과가 있다고 알려진 비타민C를 각각 50% 에탄올수용액에 1mg/mL 농도로 녹인 후 흡광도 0.94 ~ 0.98의 DPPH(1,1-diphenyl-2-picrylhydrazyl) 용액에 10% 비율로 첨가한 후 10분간 방치한다. 10분이 지난 후 흡광도를 측정하여 라디칼 소거율을 계산한다. 라디칼 소거율을 계산하는 방법은 다음과 같다.The composition 2 of Example 1 and vitamin C, which is known to have antioxidative effects, were each dissolved in a 50% ethanol aqueous solution at a concentration of 1 mg / mL and then added to a DPPH (1,1-diphenyl-2-picrylhydrazyl) solution having an absorbance of 0.94 to 0.98 in a 10% And then allowed to stand for 10 minutes. The absorbance is measured after 10 minutes to calculate the radical scavenging rate. The method of calculating the radical scavenging rate is as follows.
라디칼 소거율(%) = (초기흡광도 - 10분후 흡광도) / 초기흡광도 X 100 Radical scavenging rate (%) = (initial absorbance - absorbance after 10 minutes) / initial absorbance X 100
실험예 1의 결과를 [도 3]에 나타내었다. [도 3]의 결과와 같이 본 발명의 조성물은 비타민 C와 동등한 정도의 항산화 활성을 갖고 있다.The results of Experimental Example 1 are shown in Fig. As shown in Fig. 3, the composition of the present invention has an antioxidative activity equivalent to that of vitamin C.
실험예 2. 조성물의 항염증 효과 평가Experimental Example 2. Evaluation of anti-inflammatory effect of the composition
조성물의 동물에 대한 항염증 효과를 확인하기 위해 쥐의 대식세포 세포주(RAW 264.7)에 LPS(lipopolysaccharide)를 처리한 후 NO, PGE2, COX-2 농도를 측정하여 항염 효과를 평가하였다.To evaluate the anti-inflammatory effect of the composition on animals, the macrophage cell line (RAW 264.7) in rats was treated with LPS (lipopolysaccharide) and the NO, PGE2 and COX-2 levels were measured to evaluate the anti-inflammatory effect.
NO 농도의 측정은 배양세포에 실시예 1의 조성물 2를 농도별(30 ~ 120μg/mL)로 전처리한 후 1시간 뒤 LPS를 처리하여 염증반응을 유도하였다. LPS 처리 24시간 후 배양액과 동량의 그리스시약(Griess reagent)을 섞어 530nm에서 흡광도를 측정하였다. NO 농도 계산을 위해 NaNO2의 농도별 흡광도를 이용하여 표준곡선을 작성한 후 농도를 계산하였다. NO concentration was measured by incubating the cultured cells with the composition 2 of Example 1 (30 ~ 120 쨉 g / mL) for 1 hour, followed by treatment with LPS to induce an inflammatory reaction. After 24 hours of LPS treatment, the culture solution was mixed with an equal amount of a Griess reagent and absorbance was measured at 530 nm. For the NO concentration calculation, a standard curve was created using the absorbance of NaNO 2 concentration, and the concentration was calculated.
PGE2, COX-2의 농도는 효소결합면역흡착제 검정법(ELISA assay)을 사용하여 측정하였다. 세포배양액에 LPS와 조성물을 처리한 후 하루가 경과했을 때 효소결합면역흡착 키트에 접종한 후 540nm에서 흡광도를 측정하였다. 각 단백질의 농도는 표준품을 농도별로 처리한 흡광도 결과를 이용하여 4-PL logistic curve fit로 표준곡선을 작성한 후 농도를 계산하였다. 항염 효과 평가 결과를 [도 4] ~ [도 6]에 나타내었다. 실험 결과의 유의성은 T-test를 이용하여 확인하였고 P < 0.05를 기준으로 하였다(* P < 0.05 vs control, # P < 0.05 vs LPS).The concentrations of PGE2 and COX-2 were measured using an enzyme-linked immunosorbent assay (ELISA assay). The cell culture medium was inoculated into the enzyme-coupled immunosorbent kit one day after the treatment with LPS and the composition, and the absorbance was measured at 540 nm. Concentrations of each protein were calculated by preparing a standard curve with a 4-PL logistic curve fit using absorbance results obtained by treating standard products in concentration-dependent manner. The anti-inflammatory effect evaluation results are shown in [FIG. 4] to [FIG. 6]. The significance of the test results was confirmed by using T-test and P <0.05 (* P <0.05 vs control, P <0.05 vs LPS).
[도 4] ~ [도 6]의 실험결과와 같이 본 발명의 조성물은 LPS로 인해 발생한 염증반응을 유의미하게 경감시키는 것을 확인할 수 있다.As shown in the results of FIGS. 4 to 6, it can be confirmed that the composition of the present invention significantly alleviated the inflammatory reaction caused by LPS.
[도 4]에 의하면, 쥐의 대식세포를 이용한 실험에서 LPS와 함께 본 발명의 조성물을 처리한 경우 NO의 농도가 감소하는 것을 확인할 수 있고 농도가 높아질수록 NO의 농도가 더욱 감소하는 것을 알 수 있다. 이는 본 발명의 조성물이 LPS로 인해 발생한 염증반응 생성물인 NO의 생성을 억제해 염증을 경감시킴을 의미한다.According to FIG. 4, when the composition of the present invention was treated with LPS in a mouse macrophage, the NO concentration was decreased, and the NO concentration was further decreased as the concentration was increased have. This means that the composition of the present invention reduces inflammation by inhibiting the production of NO, an inflammatory reaction product caused by LPS.
[도 5]에 의하면, 쥐의 대식세포를 이용한 실험에서 LPS와 함께 본 발명의 조성물을 처리한 경우 COX-2의 농도가 감소하는 것을 확인할 수 있고 농도가 높아질수록 COX-2의 농도가 더욱 감소하는 것을 알 수 있다. 이는 본 발명의 조성물이 LPS로 인해 발생한 염증반응 단백질인 COX-2의 생성을 억제해 염증을 경감시킴을 의미한다.5, when the composition of the present invention was treated with LPS in a mouse macrophage, the concentration of COX-2 decreased, and as the concentration increased, the concentration of COX-2 decreased further . This means that the composition of the present invention reduces inflammation by inhibiting the production of COX-2, an inflammatory response protein caused by LPS.
[도 6]에 의하면, 쥐의 대식세포를 이용한 실험에서 LPS와 함께 본 발명의 조성물을 처리한 경우 PGE2의 농도가 감소하는 것을 확인할 수 있고 농도가 높아질수록 PGE2의 농도가 더욱 감소하는 것을 알 수 있다. 이는 본 발명의 조성물이 LPS로 인해 발생한 염증반응 단백질인 PGE2의 생성을 억제해 염증을 경감시킴을 의미한다.According to FIG. 6, when the composition of the present invention was treated with LPS in a mouse macrophage, the concentration of PGE2 decreased, and the concentration of PGE2 was further decreased as the concentration increased have. This means that the composition of the present invention suppresses inflammation by inhibiting the production of PGE2, an inflammatory response protein caused by LPS.
실험예 3. 제품예 1, 2의 효능 평가 실험Experimental Example 3. Evaluation of efficacy of Product Examples 1 and 2
제품예 1의 분말을 0.1g 취해 캡슐형태로 제조한 샘플과, 제품예 2의 샘플을 실험대상 동물에 1개월 동안 사료와 함께 지속적으로 급여하였다. 급여 전, 후 실험대상 동물의 냄새, 변색깔, 변냄새, 털의 윤기를 평가하여 제품예의 효능을 평가하였다. 평가 방법은 5점 척도를 사용하여 2(나쁨), 4, 6, 8, 10(좋음)으로 평가하였다. 객관적 실험 결과를 위해 실험대상 동물은 건강에 이상이 없는 동물만 선별해 진행했고, 실험대상 동물 종은 개로 했다. 실험 동물의 체중에 따라 제품예 1은 15kg 미만의 동물에 1캡슐, 15 ~ 30kg 미만의 동물은 2캡슐, 30kg이상의 동물은 3캡슐을 사료와 섞어 1일 2회 급여하였다. 제품예 2는 15kg 미만의 동물은 1.5 g, 15 ~ 30kg 미만의 동물은 2.5 g, 30kg이상의 동물은 5 g을 사료와 함께 1일 2회 급여하였다. 제품예 1, 2를 급여한 동물에 대한 평가를 아래의 [표 4]에 나타내었다.A sample prepared by taking 0.1 g of the powder of Product Example 1 in the form of a capsule and the sample of Product Example 2 were continuously fed to the experimental animals together with feed for one month. The efficacy of the product samples was evaluated by evaluating the smell, color change, odor and hair gloss of the animals before and after the feeding. The evaluation method was evaluated as 2 (bad), 4, 6, 8, 10 (good) using the 5-point scale. For the objective test results, only the animals that did not have any abnormality in health were selected and the experimental animals were opened. According to the weight of the experimental animals, in Example 1, 1 capsule was administered to animals less than 15 kg, 2 capsules for animals less than 15 to 30 kg, and 3 capsules for animals over 30 kg were fed twice a day. In Product Example 2, 1.5 g of the animal less than 15 kg, 2.5 g of the animal less than 15 to 30 kg, and 5 g of the animal more than 30 kg were fed twice daily with the feed. The evaluation of the animals fed the product examples 1 and 2 is shown in the following [Table 4].
표의 실험결과와 같이 본 발명의 제품예 1, 2 모두 급여한 동물의 털의 윤기, 냄새, 변냄새, 변색깔을 개선함을 확인할 수 있었다.As shown in the results of the table, it was confirmed that the product examples 1 and 2 of the present invention improved the gloss, smell, odor, and color of the hairs of the fed animals.
구분division 효능평가 (점수가 높을수록 좋음)Efficacy assessment (the higher the score, the better)
털의윤기Gloss of hair 냄새smell 변냄새Odor 변색깔Stained color
급여전Salary before 급여후After salary 급여전Salary before 급여후After salary 급여전Salary before 급여후After salary 급여전Salary before 급여후After salary
제품예 1Product Example 1 5.65.6 88 5.65.6 8.88.8 4.64.6 7.87.8 5.65.6 7.47.4
제품예2Product Example 2 5.45.4 88 5.65.6 8.68.6 4.24.2 6.66.6 5.65.6 7.27.2
실험예 4. 제품예 2의 비만개선 효능 평가 실험Experimental Example 4. Observation of Obesity Improvement Efficacy of Product Example 2
제품예 2의 동물사료의 비만개선 효능을 평가하기 위해 정상체중보다 20%정도 과체중인 개 10마리를 선정하여 사료를 급여할 때 제품예 2를 섞어 급여하였다. 제품예 2는 15kg 미만의 동물은 1.5 g, 15 ~ 30kg 미만의 동물은 2.5 g, 30kg이상의 동물은 5 g을 1일 2회 급여하였고 한달간 지속적으로 급여한 후 전후 몸무게를 비교해 비만개선 효과를 평가하였다. 객관적 실험결과를 위해 실험대상 동물은 성장이 끝난 동물을 선정하였으며, 비만 이외 다른 이상이 없는 동물로 선정하였다. 동물의 과체중률은 견종별 표준체중을 활용하여 아래의 식과 같이 계산하였다.In order to evaluate the efficacy of the animal feed of Example 2 for improving obesity, 10 dogs that were overweight by 20% of their normal weight were selected and fed with the product Example 2 when they were fed. In Example 2, 1.5 g of the animal less than 15 kg, 2.5 g of the animal less than 15 to 30 kg, and 5 g of the animal more than 30 kg were fed twice a day, and the obesity improvement effect was evaluated by comparing the post- Respectively. For the objective test results, the animals were selected from the animals that had undergone growth, and those without obesity were selected. The overweight of the animals was calculated by the following formula using the standard weight per breed.
과체중률(%) = (현재체중 - 정상체중)/정상체중 Overweight (%) = (current weight - normal weight) / normal weight
제품예 2의 비만개선 효능 평가 실험 결과를 아래의 [표 5]에 나타내었다.The results of the evaluation of the obesity-improving efficacy of the product Example 2 are shown in Table 5 below.
표의 실험결과와 같이 본 발명의 제품예 2를 급여한 개의 비만이 개선됨을 확인할 수 있었다.As shown in the experimental results of the table, it was confirmed that the obesity of the dog fed with the product Example 2 of the present invention was improved.
구분division 급여전 과체중률(%)Overweight before pay (%) 급여후 과체중률(%)Overweight after pay (%)
제품예 2Product Example 2 20.6920.69 8.178.17
본 발명은 갈조류로부터 추출한 플로로탄닌을 포함하는 조성물을 사용하는 것으로 동물에게 안전하게 적용이 가능하고 동물의 털의 윤기, 냄새, 변냄새, 변색깔을 개선하고 과체중을 개선할 수 있다.The present invention uses a composition containing florotannin extracted from brown algae, which can be safely applied to animals, and can improve the gloss, odor, odor, color, and overweight of animal hair.

Claims (13)

  1. 플로로탄닌 화합물을 유효성분으로 포함하는 동물사료용 조성물Animal feed composition comprising a phlorotannin compound as an active ingredient
  2. 청구항 1에 있어서, 상기 플로로탄닌 화합물은 하기 화학식 1 ~ 화학식 12로 표시되는 플로로탄닌 중에서 선택되는 1종 이상인 것을 특징으로 하는 동물사료용 조성물The animal feed composition according to claim 1, wherein the phlorotannin compound is at least one selected from the group consisting of phlorotannines represented by the following general formulas (1) to (12)
    [화학식 1][Chemical Formula 1]
    Figure PCTKR2019001025-appb-I000013
    Figure PCTKR2019001025-appb-I000013
    [화학식 2](2)
    Figure PCTKR2019001025-appb-I000014
    Figure PCTKR2019001025-appb-I000014
    [화학식 3](3)
    Figure PCTKR2019001025-appb-I000015
    Figure PCTKR2019001025-appb-I000015
    [화학식 4][Chemical Formula 4]
    Figure PCTKR2019001025-appb-I000016
    Figure PCTKR2019001025-appb-I000016
    [화학식 5][Chemical Formula 5]
    Figure PCTKR2019001025-appb-I000017
    Figure PCTKR2019001025-appb-I000017
    [화학식 6][Chemical Formula 6]
    Figure PCTKR2019001025-appb-I000018
    Figure PCTKR2019001025-appb-I000018
    [화학식 7](7)
    Figure PCTKR2019001025-appb-I000019
    Figure PCTKR2019001025-appb-I000019
    [화학식 8][Chemical Formula 8]
    Figure PCTKR2019001025-appb-I000020
    Figure PCTKR2019001025-appb-I000020
    [화학식 9][Chemical Formula 9]
    Figure PCTKR2019001025-appb-I000021
    Figure PCTKR2019001025-appb-I000021
    [화학식 10][Chemical formula 10]
    Figure PCTKR2019001025-appb-I000022
    Figure PCTKR2019001025-appb-I000022
    [화학식 11](11)
    Figure PCTKR2019001025-appb-I000023
    Figure PCTKR2019001025-appb-I000023
    [화학식 12][Chemical Formula 12]
    Figure PCTKR2019001025-appb-I000024
    Figure PCTKR2019001025-appb-I000024
  3. 청구항 1에 있어서, 상기 조성물은 총 플로로탄닌 화합물을 20 ~ 100중량% 포함하는 것을 특징으로 하는 동물사료용 조성물The composition according to claim 1, wherein the composition comprises 20 to 100% by weight of a total phlorotannin compound
  4. 청구항 1에 있어서, 상기 조성물은 화학식 2, 화학식 4, 화학식 5 및 화학식 8로 이루어진 그룹에서 선택되는 1종 이상의 플로로탄닌을 포함하는 것을 특징으로 하는 동물사료용 조성물The composition for animal feed according to claim 1, wherein the composition comprises at least one kind of phlorotannin selected from the group consisting of formulas (2), (4), (5) and
  5. 청구항 4에 있어서, 상기 조성물은 화학식 2의 플로로탄닌 1 내지 60중량%, 화학식 4의 플로로탄닌 0.3 내지 20중량%, 화학식 5의 플로로탄닌 0.1 내지 10중량% 또는 화학식 8의 플로로탄닌 0.1 내지 5중량%를 포함하는 것을 특징으로 하는 동물사료용 조성물The composition of claim 4, wherein the composition comprises 1 to 60 wt% of a fluorotannine of Formula 2, 0.3 to 20 wt% of a fluorotannine of Formula 4, 0.1 to 10 wt% of a fluorotannine of Formula 5, 0.1 to 5% by weight of an animal feed composition
  6. 청구항 1에 있어서, 상기 동물사료용 조성물이 해조류 추출물인 것을 특징으로 하는 동물사료용 조성물The animal feed composition according to claim 1, wherein the animal feed composition is an algae extract
  7. 청구항 1에 있어서, 상기 플로로탄닌 화합물이 대황(Eisenia bicyclis), 아이세니아 아르보레아(Eisenia arborea), 아이세니아 데스마레스티오데스(Eisenia desmarestioides), 아이세니아 갈라파제니스(Eisenia galapagensis), 아이세니아 매소니(Eisenia masonii), 검둥감태(Ecklonia kurome), 감태(Ecklonia cava), 곰피(Ecklonia stolonifera), 바다대나무(Ecklonia maxima), 에클로니아 라디아타(Ecklonia radiata), 에클로니아 바이시클리스(Ecklonia bicyclis), 에클로니아 바이런시네이트(Ecklonia biruncinate), 에클로니아 부시날리스(Ecklonia buccinalis), 에클로니아 카에파에스팁스(Ecklonia caepaestipes), 에클로니아 엑사스퍼타(Ecklonia exasperta), 에클로니아 파스티기아타(Ecklonia fastigiata), 에클로니아 브레빕스(Ecklonia brevipes), 에클로니아 아라보레아(Ecklonia arborea), 에클로니아 라티폴리아(Ecklonia latifolia), 에클로니아 무라티(Ecklonia muratii), 에클로니아 라디코사(Ecklonia radicosa), 에클로니아 리타디아나(Ecklonia richardiana) 및 에클로니아 라이티(Ecklonia wrightii)로 이루어진 그룹으로부터 선택된 1종 이상의 해조류로부터 추출하는 것을 특징으로 하는 동물사료용 조성물The method of claim 1, wherein the fluorotannine compound is selected from the group consisting of Eisenia bicyclis, Eisenia arborea, Eisenia desmarestioides, Eisenia galapagensis, (Ecklonia radiata), Eclonia bacillus (Ecklonia spp.), Ecklonia cava, Ecklonia stolonifera, Sea bamboo (Ecklonia maxima), Ecklonia radiata, Ecklonia bicyclis), Ecklonia biruncinate, Ecklonia buccinalis, Ecklonia caepaestipes, Ecklonia exasperta, Ecologia pasty, Ecklonia fastigiata, Ecklonia brevipes, Ecklonia arborea, Ecklonia latifolia, Ecklonia latifolia, wherein the composition is extracted from at least one kind of seaweed selected from the group consisting of lonia muratii, Ecklonia radicosa, Ecklonia richardiana and Ecklonia wrightii.
  8. 청구항 3에 있어서, 플로로탄닌 20~100중량%, 만니톨 0 내지 30 중량%, 알긴산 0 내지 25 중량%, 푸코이단 0 내지 25 중량%, 푸코스테롤 0 내지 10 중량%, 푸코잔틴 0 내지 10 중량% 및 라미나란 0 내지 10 중량%을 포함하는 것을 특징으로 하는 동물사료용 조성물The method of claim 3, wherein the composition comprises 20 to 100% by weight of fluorotannine, 0 to 30% by weight of mannitol, 0 to 25% by weight of alginic acid, 0 to 25% by weight of fucoidan, 0 to 10% by weight of fucosterol, 0 to 10% And 0 to 10% by weight of laminaran.
  9. 청구항 1의 조성물을 포함하는 동물용 제품Animal product comprising the composition of claim 1
  10. 청구항 9에 있어서, 상기 제품은 동물용 사료, 동물용 통조림 또는 개껌의 형태인 것을 특징으로 하는 동물용 제품10. An animal product according to claim 9, characterized in that the product is in the form of animal feed, canned food for animals or gum
  11. 청구항 9에 있어서, 상기 제품은 상기 조성물을 제품 총 중량대비 0.1 ~ 50중량% 포함하는 것을 특징으로 하는 동물용 제품The animal product according to claim 9, wherein the product comprises 0.1 to 50% by weight of the composition, based on the total weight of the product.
  12. 청구항 9에 있어서, 상기 제품은 콜라겐, 아마씨추출물, 칼슘, 철분, 비타민 B12, 비타민 E 및 구리로 이루어진 그룹으로부터 선택되는 1종 이상을 더 포함하는 것을 특징으로 하는 동물용 제품[Claim 11] The animal product according to claim 9, wherein the product further comprises at least one member selected from the group consisting of collagen, flaxseed extract, calcium, iron, vitamin B12, vitamin E and copper
  13. 청구항 9에 있어서, 상기 제품은 플로로탄닌 조성물 1 ~ 50중량%, 콜라겐 40 ~ 80중량%, 아마씨추출물 1 ~ 6중량%, 칼슘 0.001 ~ 18중량%, 철분 0.1 ~ 1중량%, 비타민 B12 0.00001 ~ 0.01중량%, 비타민 E 0.1 ~ 0.5중량% 및 구리 0.05 ~ 0.1중량%를 포함하는 동물용 제품The method of claim 9, wherein the product comprises 1 to 50% by weight of a phlorotannin composition, 40 to 80% by weight of collagen, 1 to 6% by weight of flaxseed extract, 0.001 to 18% by weight of calcium, 0.1 to 1% by weight of iron, To 0.01% by weight of vitamin E, 0.1 to 0.5% by weight of vitamin E and 0.05 to 0.1% by weight of copper
PCT/KR2019/001025 2018-01-25 2019-01-24 Composition for animal feed comprising phlorotannin as active ingredient and product for animal WO2019147044A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201980009505.5A CN111669976A (en) 2018-01-25 2019-01-24 Composition for animal feed containing brown algae polyphenol as active ingredient and animal product

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180009440 2018-01-25
KR10-2018-0009440 2018-01-25

Publications (1)

Publication Number Publication Date
WO2019147044A1 true WO2019147044A1 (en) 2019-08-01

Family

ID=67394672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/001025 WO2019147044A1 (en) 2018-01-25 2019-01-24 Composition for animal feed comprising phlorotannin as active ingredient and product for animal

Country Status (3)

Country Link
KR (1) KR102192712B1 (en)
CN (1) CN111669976A (en)
WO (1) WO2019147044A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2579600B (en) * 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102389589B1 (en) 2021-09-29 2022-04-22 진지영 Antifungal composition comprising spirits extract of Lespedeza cuneata and process for preparing the same
KR20230054016A (en) 2021-10-15 2023-04-24 진지영 Antiseptic composition and process for preparing the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041932A2 (en) * 2008-10-06 2010-04-15 Coulisse B.V. System of a number of remotely controllable screens, such as window coverings, a remote control for operating the screens and a method intended for application with the system
WO2012096475A2 (en) * 2011-01-13 2012-07-19 주식회사 보타메디 Composition for a functional food having the effect of restoring blood composition and function
KR101542882B1 (en) * 2013-10-30 2015-08-10 한국생명공학연구원 A composition for prevention and treatment of fish viral hemorrhagic septicemia containing extracts of Ecklonia cava
KR20170050392A (en) * 2015-10-30 2017-05-11 주식회사 보타메디 Beverage composition comprising phlorotannin, ginseng extract and caffeine
KR101772335B1 (en) * 2016-07-15 2017-09-12 성균관대학교산학협력단 A composition for treating, improving and preventing of papilloma virus infection comprising phlorotannin

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4105535B2 (en) * 2002-12-10 2008-06-25 熊本県 Antiviral substance
KR20050099436A (en) 2004-04-10 2005-10-13 김정성 A road warning lamp
KR20100039104A (en) * 2008-10-07 2010-04-15 부경대학교 산학협력단 An anti-oxidant active composition containing compounds from ishige okamurae
KR20100039106A (en) * 2008-10-07 2010-04-15 부경대학교 산학협력단 An anti-allergy active composition containing compounds from ecklonia cava
KR101245349B1 (en) * 2008-10-07 2013-03-20 부경대학교 산학협력단 A pharmaceutical composition for inhibiting HIV-1 containing phloroglucinol copolymer compound from Ecklonia cava
KR101201524B1 (en) * 2010-02-03 2012-11-14 주식회사 보타메디 Composition for improvement of health of scalp and hair comprising dibenzo-p-dioxin derivatives
US10646529B2 (en) * 2010-03-15 2020-05-12 Board Of Trustees, Rutgers, The State University Of New Jersey Methods of obtaining natural products from the comestible fluids and methods of use
KR102006501B1 (en) * 2012-06-18 2019-08-01 부경대학교 산학협력단 Antibiotics Composition Containing Phlorotannins from Eisenia bicyclis
WO2015178728A1 (en) * 2014-05-23 2015-11-26 주식회사 비비에이치씨 Method for preparing induced pluripotency stem cells from mesenchymal stem cells by using phlorotannin fraction
CN104829740B (en) * 2015-05-12 2017-04-12 上海海洋大学 Method for synchronously extracting sargassum graminifolium polysaccharide and sargassum graminifolium polyphenol from sargassum graminifolium
KR101777842B1 (en) 2016-05-04 2017-09-14 주식회사 엘에스과학기술원 Feed with seawater and aweed, and manufacturing method of the same
KR101966124B1 (en) * 2016-11-10 2019-04-05 조선대학교산학협력단 Composition comprising extract of Ecklonia cava or phlorotannin compounds isolated from thereof for preventing or treating influenza
KR102050585B1 (en) * 2017-07-21 2019-12-02 주식회사 보타메디 Phlorotannin composition having inhibitory effect on induction of gray hair and promoting effect on induction of dark hair

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041932A2 (en) * 2008-10-06 2010-04-15 Coulisse B.V. System of a number of remotely controllable screens, such as window coverings, a remote control for operating the screens and a method intended for application with the system
WO2012096475A2 (en) * 2011-01-13 2012-07-19 주식회사 보타메디 Composition for a functional food having the effect of restoring blood composition and function
KR101542882B1 (en) * 2013-10-30 2015-08-10 한국생명공학연구원 A composition for prevention and treatment of fish viral hemorrhagic septicemia containing extracts of Ecklonia cava
KR20170050392A (en) * 2015-10-30 2017-05-11 주식회사 보타메디 Beverage composition comprising phlorotannin, ginseng extract and caffeine
KR101772335B1 (en) * 2016-07-15 2017-09-12 성균관대학교산학협력단 A composition for treating, improving and preventing of papilloma virus infection comprising phlorotannin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2579600B (en) * 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition

Also Published As

Publication number Publication date
CN111669976A (en) 2020-09-15
KR102192712B1 (en) 2020-12-18
KR20190090715A (en) 2019-08-02

Similar Documents

Publication Publication Date Title
Liu et al. The protective role of glutamine on enteropathy induced by high dose of soybean meal in turbot, Scophthalmus maximus L.
Huang et al. Effects of fishmeal replacement by black soldier fly on growth performance, digestive enzyme activity, intestine morphology, intestinal flora and immune response of pearl gentian grouper (Epinephelus fuscoguttatus♀× Epinephelus lanceolatus♂)
Ghafarifarsani et al. Effects of dietary vitamin C, thyme essential oil, and quercetin on the immunological and antioxidant status of common carp (Cyprinus carpio)
WO2016122234A1 (en) Composition for drinking water agent and feed having companion animal urine odor removal function, comprising mixture of herbal extracts as effective ingredient
WO2019147044A1 (en) Composition for animal feed comprising phlorotannin as active ingredient and product for animal
Gao et al. Effects of novel microecologics combined with traditional Chinese medicine and probiotics on growth performance and health of broilers
Chen et al. Effects of dietary Lactobacillus rhamnosus CF supplementation on growth, meat quality, and microenvironment in specific pathogen-free chickens
Zhang et al. Effects of Lycium barbarum polysaccharides on immunological parameters, apoptosis, and growth performance of Nile tilapia (Oreochromis niloticus)
Simonová et al. Can enterocins affect phagocytosis and glutathione-peroxidase in rabbits?
WO2020142305A1 (en) Feed supplements
Li et al. Coix seed improves growth performance and productivity in post-weaning pigs by reducing gut pH and modulating gut microbiota
Kovács et al. Effect of dietary supplementation of Spirulina (Arthrospira platensis) and thyme (Thymus vulgaris) on serum biochemistry, immune response and antioxidant status of rabbits
Ismail et al. The optimized inclusion level of Bacillus subtilis fermented Azolla pinnata in Nile tilapia (Oreochromis niloticus) diets: immunity, antioxidative status, intestinal digestive enzymes and histomorphometry, and disease resistance
Zhang et al. Dietary Lasia spinosa Thw. improves growth performance in broilers
Guo et al. The impacts of fermented feed on laying performance, egg quality, immune function, intestinal morphology and microbiota of laying hens in the late laying cycle
Wang et al. Evaluation of the mitigation efficacy of a yeast cell wall extract toward deoxynivalenol contaminated diet fed to turbot (Scophthalmus maximus)
Pu et al. A class IIb bacteriocin plantaricin NC8 modulates gut microbiota of different enterotypes in vitro
Liu et al. Effects of fermented Andrographis paniculata on growth performance, carcass traits, immune function, and intestinal health in Muscovy ducks
Li et al. Additional supplementation of sulfur-containing amino acids in the diets improves the intestinal health of turbot fed high-lipid diets
Azad et al. Effects of dietary carboxymethyl pachyman on oxidative stress and inflammation in weaned piglets challenged with diquat
Abd El-Naby et al. Overall evaluation of the replacement of fermented soybean to fish meal in juvenile white shrimp, Litopenaeus vannamei diet: growth, health status, and hepatopancreas histomorphology
Hou et al. Effects of dietary phospholipid and cholesterol levels on antioxidant capacity, nonspecial immune response and intestinal microflora of juvenile female crayfish, Procambarus clarkii
Ji et al. The probiotic effects of host-associated Bacillus velezensis in diets for hybrid yellow catfish (Pelteobagrus fulvidraco♀× Pelteobagrus vachelli♂)
Atlanderova et al. Biological evaluation of aqueous extract of oak bark on in vitro models
JPS59108720A (en) Feed efficiency improver

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19744541

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19744541

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01.02.2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19744541

Country of ref document: EP

Kind code of ref document: A1